198 related articles for article (PubMed ID: 11683879)
1. Identification of the epidermal growth factor-like domains of thrombomodulin essential for the acceleration of thrombin-mediated inactivation of single-chain urokinase-type plasminogen activator.
Schenk-Braat EA; Morser J; Rijken DC
Eur J Biochem; 2001 Nov; 268(21):5562-9. PubMed ID: 11683879
[TBL] [Abstract][Full Text] [Related]
2. The inactivation of single-chain urokinase-type plasminogen activator by thrombin on cultured human endothelial cells.
Braat EA; Collen A; Jie AF; Grimbergen JM; Rijken DC
Biochim Biophys Acta; 2000 Sep; 1497(3):351-8. PubMed ID: 10996659
[TBL] [Abstract][Full Text] [Related]
3. The inactivation of single-chain urokinase-type plasminogen activator by thrombin in a plasma milieu: effect of thrombomodulin.
Braat EA; Los P; Rijken DC
Blood Coagul Fibrinolysis; 1998 Jul; 9(5):419-27. PubMed ID: 9712290
[TBL] [Abstract][Full Text] [Related]
4. Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin.
de Munk GA; Groeneveld E; Rijken DC
J Clin Invest; 1991 Nov; 88(5):1680-4. PubMed ID: 1658049
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin is a cofactor for thrombin degradation of recombinant single-chain urokinase plasminogen activator "in vitro" and in a perfused rabbit heart model.
Molinari A; Giorgetti C; Lansen J; Vaghi F; Orsini G; Faioni EM; Mannucci PM
Thromb Haemost; 1992 Feb; 67(2):226-32. PubMed ID: 1320301
[TBL] [Abstract][Full Text] [Related]
6. Role of the glycosaminoglycan component of thrombomodulin in its acceleration of the inactivation of single-chain urokinase-type plasminogen activator by thrombin.
de Munk GA; Parkinson JF; Groeneveld E; Bang NU; Rijken DC
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):655-9. PubMed ID: 8384442
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-mediated fibrinolysis in the synovial fluid of rheumatoid arthritis patients may be affected by the inactivation of single chain urokinase type plasminogen activator by thrombin.
Braat EA; Jie AF; Ronday HK; Beekman B; Rijken DC
Ann Rheum Dis; 2000 Apr; 59(4):315-8. PubMed ID: 10733483
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis.
Fleury V; Lijnen HR; Anglés-Cano E
J Biol Chem; 1993 Sep; 268(25):18554-9. PubMed ID: 8103046
[TBL] [Abstract][Full Text] [Related]
9. A sensitive bioimmunoassay for thrombin-cleaved two-chain urokinase-type plasminogen activator in human body fluids.
Braat EA; Nauland U; Dooijewaard G; Rijken DC
Thromb Haemost; 1996 Jun; 75(6):908-14. PubMed ID: 8822585
[TBL] [Abstract][Full Text] [Related]
10. Activation with plasmin of tow-chain urokinase-type plasminogen activator derived from single-chain urokinase-type plasminogen activator by treatment with thrombin.
Lijnen HR; Van Hoef B; Collen D
Eur J Biochem; 1987 Dec; 169(2):359-64. PubMed ID: 2961562
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of receptor-bound pro-urokinase-type plasminogen activator (pro-uPA) by thrombin and thrombin/thrombomodulin complex.
Wilhelm S; Wilhelm O; Schmitt M; Graeff H
Biol Chem Hoppe Seyler; 1994 Sep; 375(9):603-8. PubMed ID: 7840902
[TBL] [Abstract][Full Text] [Related]
12. Activation of thrombin-activable fibrinolysis inhibitor requires epidermal growth factor-like domain 3 of thrombomodulin and is inhibited competitively by protein C.
Kokame K; Zheng X; Sadler JE
J Biol Chem; 1998 May; 273(20):12135-9. PubMed ID: 9575159
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of single-chain urokinase-type plasminogen activator by thrombin in human subjects.
Braat EA; Levi M; Bos R; Haverkate F; Lassen MR; de Maat MP; Rijken DC
J Lab Clin Med; 1999 Aug; 134(2):161-7. PubMed ID: 10444030
[TBL] [Abstract][Full Text] [Related]
14. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells.
Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB
J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462
[TBL] [Abstract][Full Text] [Related]
15. Fibrin specific thrombolysis by two-chain urokinase-type plasminogen activator cleaved after arginine 156 by thrombin.
Abercrombie DM; Buchinski B; Salvato KA; Vovis GF; Stump DC; Broeze RJ
Thromb Haemost; 1990 Nov; 64(3):426-32. PubMed ID: 2128973
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of single-chain urokinase (pro-urokinase) by thrombin and thrombin-like enzymes: relevance of the findings to the interpretation of fibrin-binding experiments.
Gurewich V; Pannell R
Blood; 1987 Mar; 69(3):769-72. PubMed ID: 2949785
[TBL] [Abstract][Full Text] [Related]
17. Elements of the primary structure of thrombomodulin required for efficient thrombin-activable fibrinolysis inhibitor activation.
Wang W; Nagashima M; Schneider M; Morser J; Nesheim M
J Biol Chem; 2000 Jul; 275(30):22942-7. PubMed ID: 10801821
[TBL] [Abstract][Full Text] [Related]
18. Activation of thrombin-inactivated single-chain urokinase-type plasminogen activator by dipeptidyl peptidase I (cathepsin C).
Nauland U; Rijken DC
Eur J Biochem; 1994 Jul; 223(2):497-501. PubMed ID: 8055919
[TBL] [Abstract][Full Text] [Related]
19. Energetics of thrombin-thrombomodulin interaction.
Vindigni A; White CE; Komives EA; Di Cera E
Biochemistry; 1997 Jun; 36(22):6674-81. PubMed ID: 9184147
[TBL] [Abstract][Full Text] [Related]
20. Pig thrombomodulin binds human thrombin but is a poor cofactor for activation of human protein C and TAFI.
Roussel JC; Moran CJ; Salvaris EJ; Nandurkar HH; d'Apice AJ; Cowan PJ
Am J Transplant; 2008 Jun; 8(6):1101-12. PubMed ID: 18444940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
